on APRETUDE vs TRUVADA during the study. IMPORTANT SAFETY INFORMATION (cont d) Before receiving APRETUDE, tell your healthcare provider about all your medical conditions, including if you: (cont d) are pregnant or plan to become pregnant. It is not known if APRETUDE will harm your unborn
☐ Medication is Truvada (tenofovir-emtricitabine), Descovy (emtricitabine and tenofovir alafenamide) or Apretude (cabotegravir); and. ☐ No
TRUVADA, respectively. During the oral lead-in period, 4 ( 1 suspension) or APRETUDE should be consulted to ensure use of CABENUVA or APRETUDE.
Truvada, Descovy, and Apretude: Truvada is in the form of a pill and is for all people at risk for HIV through sex or injection drug use.
(generic TDF/FTC, Truvada or Descovy). If PrEP is indicated, prescribe The federal guidance does not mention Apretude, and Apretude (or any long-acting.
There are two pills approved for use as PrEP: Truvada and Descovy. Truvada Apretude is the only shot approved for use as PrEP. Apretude is for
In a second trial, 3,224 cisgender women received either Apretude or Truvada. In the end, the women who took Apretude had a 90% less risk of getting infected with HIV versus those who took Truvada.
Those taking Apretude had a 90% lower risk of getting an HIV infection compared to those who took Truvada. Do not miss any Apretude injections
APRETUDE compared with TRUVADA. There is no head-to-head comparison between APRETUDE and DESCOVY. On Decem, the Food and Drug Administration
Look it up. It reduces risk of transmission markedly